Royal College of Surgeons in Ireland
|As first author||6|
|As last author||50|
Denis C. Shields(13)
F E Murray(11)
P B Maguire(7)
Glen A Doherty(7)
Andrew O Maree(7)
Anthony P Fitzgerald(6)
Elaine W Kay(5)
Colm J O'Brien(4)
Eamonn S Molloy(4)
Steven W Kerrigan(3)
Geraldine M McCarthy(3)
... and 42 others
These arethe9 unique sources for D J Fitzgerald's 101 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.
|Ireland -> Royal College of Surgeons in Ireland||79|
|Ireland -> Royal College of Surgeons in Ireland -> PubMed||76|
|Ireland -> Teagasc||1|
|Ireland -> Teagasc -> PubMed||1|
|Ireland -> Trinity College Dublin||1|
|Ireland -> University College Dublin||18|
|Ireland -> University College Dublin -> PubMed||18|
|Ireland -> University of Limerick||2|
|Ireland -> University of Limerick -> PubMed||2|
A conjugated linoleic acid (CLA) derivative having the structure (I) wherein n is an integer from 1 to 10
A method of detecting in an individual incomplete inhibition an enzyme involved in thrombus formation, especially platelet cyclooxygesane, is described. The method comprises the steps of obtaining from the individual a biological sample which contains the enzyme, adding an exogenous substrate for the enzyme to the sample to form a reaction mixture, and assaying the reaction mixture for any increase in a level of a metabolite of the enzyme. The method is especially suitable for detecting sub-optimal ASPIRIN inhibition in individuals undergoing ASPIRIN anti-thrombosis therapy. Kits for carrying out the method of the invention are also described.
A method of inhibiting platelet activation in an human subject comprises the step of treating the subject with an agent which has an effect of preventing or disrupting an association between a nucleotide sensitive chloride channel ICLn and a platelet specific Integrin alphaIIbbeta3. The agent may be an inhibitor of the nucleotide sensitive chloride channel ICLn or a ligand having at least a mM binding affinity for an amino acid sequence KVGFFKR, such as a peptide comprising the sequence AKFEEE or the sequence KVGAAKR.
Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.
Here is a quick breakdown of this expert's publication history
If this is the expert you have been looking for, simply click here to make contact.